Sign In
Buy WHWK
$4.15
-0.250 (-5.68%)
At Close: Jun 05, 2026
David James Lennon Sells 26,858 Shares of Whitehawk Therapeutics (NASDAQ:WHWK) Stock
05:56am, Sunday, 05'th Apr 2026
Whitehawk Therapeutics, Inc. (NASDAQ: WHWK - Get Free Report) CEO David James Lennon sold 26,858 shares of Whitehawk Therapeutics stock in a transaction that occurred on Thursday, April 2nd. The share
MORRISTOWN, N.J., March 17, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biolog
Ally Bridge Group NY LLC Takes $1.55 Million Position in Whitehawk Therapeutics, Inc. $WHWK
03:31am, Sunday, 15'th Mar 2026
Ally Bridge Group NY LLC acquired a new stake in Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchan
2,849,402 Shares in Whitehawk Therapeutics, Inc. $WHWK Purchased by Avoro Capital Advisors LLC
03:07am, Saturday, 14'th Mar 2026
Avoro Capital Advisors LLC acquired a new position in shares of Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) in the undefined quarter, according to its most recent 13F filing with the Securities and Ex
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
08:00am, Thursday, 12'th Mar 2026
Actively recruiting Phase 1 trials for PTK7-targeted antibody-drug conjugate (ADC) HWK-007 and MUC16-targeted ADC HWK-016 HWK-206 on track for planned IND submission in mid-2026 and Phase 1 start in Q
Contrasting Whitehawk Therapeutics (NASDAQ:WHWK) & Vincerx Pharma (NASDAQ:VINC)
01:28am, Monday, 02'nd Mar 2026
Whitehawk Therapeutics (NASDAQ: WHWK - Get Free Report) and Vincerx Pharma (NASDAQ: VINC - Get Free Report) are both small-cap manufacturing companies, but which is the superior business? We will cont
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Thursday, 26'th Feb 2026
MORRISTOWN, N.J., Feb. 26, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology
Whitehawk Therapeutics (NASDAQ:WHWK) versus IMV (OTCMKTS:IMVIQ) Financial Review
03:18am, Thursday, 26'th Feb 2026
IMV (OTCMKTS:IMVIQ - Get Free Report) and Whitehawk Therapeutics (NASDAQ: WHWK - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two busine
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
08:00am, Wednesday, 18'th Feb 2026
MORRISTOWN, N.J., Feb. 18, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
08:00am, Thursday, 08'th Jan 2026
Actively recruiting Phase 1 trial for PTK7-targeted antibody-drug conjugate (ADC) HWK-007 IND submitted mid-December 2025 for MUC16-targeted ADC HWK-016, anticipated Phase 1 start this quarter Initial
Comparing Whitehawk Therapeutics (NASDAQ:WHWK) & Acerus Pharmaceuticals (OTCMKTS:TRLPF)
02:16am, Friday, 05'th Dec 2025
Acerus Pharmaceuticals (OTCMKTS:TRLPF - Get Free Report) and Whitehawk Therapeutics (NASDAQ: WHWK - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contra
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
08:00am, Monday, 01'st Dec 2025
Dr. Dugan brings extensive clinical development leadership to Whitehawk as ADC programs near the clinic MORRISTOWN, N.J. , Dec. 1, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
08:00am, Wednesday, 26'th Nov 2025
MORRISTOWN, N.J. , Nov. 26, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficientl
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London
08:00am, Tuesday, 11'th Nov 2025
MORRISTOWN, N.J. , Nov. 11, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficientl
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
08:00am, Thursday, 06'th Nov 2025
MORRISTOWN, N.J. , Nov. 6, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently
